AAKHA BIOLOGICS INC.
FRISCO, TX · Founded 2022 · CIK 0002030720 · Biotech · Private
Biotech therapeutics for rare and orphan diseases
aakha.bio →- Grants
- $400K
- 1 award
- Sector median: 1
- Raised
- $750K
- 1 Form D · Jul 2024
- 27 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 0 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A novel MICA/B based tumor-centric bispecific antibody that enhances NK cell activity in a hostile tumor microenvironment | $400,000 | |
| Private capital raised | Form D · SEC | $750,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2584 | PRAETEGO, INC. | — | $783K |
| 2585 | Indigo Biosciences Inc. | — | $782K |
| 2586 | Bit Discovery, Inc. | — | $760K |
| 2587 | AAKHA BIOLOGICS INC. | — | $750K |
| 2588 | ENDURE BIOTHERAPEUTICS, INC. | — | — |
| 2589 | ZIPPIN BIO CORPORATION | — | — |
| 2590 | SIRPANT IMMUNOTHERAPEUTICS INC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Errik AndersonDirector
- Hemanta BaruahDirector · Executive Officer
- George Mabry IIIDirector
- Christopher PachecoDirector
Patents
- Mhc Class I Chain-related Protein A (mica)-specific Antibodies And Uses Thereofapplication
- Mhc Class I Chain-related Protein A (mica)-specific Antibodies And Uses Thereofapplication
- Mhc Class I Chain-related Protein A (mica)-specific Antibodies And Uses Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.